Hepatitis colestásica por candesartán: descripción de un caso

Hermida Pérez, Benito; Izquierdo Romero, Marta; García López, Rosa.
Rev. esp. enferm. dig ; 112(12): 959-960, dic. 2020.
Artículo en Español | IBECS (España) | ID: ibc-200595

Documentos relacionados

  1. [Interpretation of the Chinese guideline for diagnosis and management of drug-induced liver injury (2023 version)].
  2. Clinical and Liver Biochemistry Phenotypes, and Outcome in 133 Patients with Anti-seizure Drug-Induced Liver Injury.
  3. Could herbal soup be a potentially unrecognized cause of hepatotoxicity at autopsy?
  4. Roles of Cofactors in Drug-Induced Liver Injury: Drug Metabolism and Beyond.
  5. Machine Learning-Based Prediction of Drug-Induced Hepatotoxicity: An OvA-QSTR Approach.
  6. Prediction of drug-induced hepatotoxicity based on histopathological whole slide images.
  7. Severe hepatotoxicity secondary to nintedanib.
  8. ResNet18DNN: prediction approach of drug-induced liver injury by deep neural network with ResNet18.
  9. Predicting drug-induced liver injury using graph attention mechanism and molecular fingerprints.
  10. Application of high throughput in vitro metabolomics for hepatotoxicity mode of action characterization and mechanistic-anchored point of departure derivation: a case study with nitrofurantoin.